NBTX — Nanobiotix S.A. American Depositary Shares
Healthcare · ETF XLV · as of 2026-09-18
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Price & today
| Stock today | -7.89% |
| Sector ETF today | -0.25% |
| Residual (stock-specific) | -7.64% |
Sector correlation
| 20-day correlation with XLV | -0.00 |
| 60-day correlation with XLV | -0.08 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $36.20 |
| 20 EMA | $37.71 |
| 50 EMA | $38.59 |
| EMA stack | BEARISH |
| RSI(14) | 36.8 |
| 52-week high distance | -42.16% |
| 52-week low distance | +311.58% |
Signals
| Market F&G | 46.9 |
| Bull% | 12.2% |
| OVTLYR status | — |
| Sector rank | — |
| Next earnings | — |
MarketSmith metrics - our compute
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
Company data - context read, not entry inputs
Recent news - our DB (Finnhub + OVTLYR)
- Aug 25 · Voting Rights and Shares Capital of the Company GlobeNewsWire
- Aug 17 · 12 Health Care Stocks Moving In Monday's Intraday Session Benzinga
- Jul 30 · Voting Rights and Shares Capital of the Company GlobeNewsWire
- Jun 25 + Nanobiotix: A Highly Speculative Bet On A Potential Radiotherapy Platform Seeking Alpha
- Jun 12 + Nanobiotix: A Royalty-Backed Physics Platform Hidden Inside A Biotech Seeking Alpha
- Jun 05 · Voting Rights and Shares Capital of the Company GlobeNewsWire
- Jun 02 · Nanobiotix Provides First Quarter 2026 Operational and Financial Update GlobeNewsWire
- Jun 02 · Nanobiotix Joins the Euronext Tech Leaders Index GlobeNewsWire